Bradley R. Teegarden

Statistics

Publications

Citations

429

H-Index

Active since

1992

Affiliations

Arena Pharmaceuticals (United States)(Current)

Bradley R. Teegarden is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicine, and 5-hydroxytryptamine receptor pharmacology.

Publications per year

1992–2010

Publications

Vancomycin and ristocetin models: synthesis via the Ullmann macrocyclization reaction

Dale L. Boger, Yuji Nomoto, Bradley R. Teegarden · The Journal of Organic Chemistry · 1993 · 77 citations

Pharmacy, Chemistry, Pharmacology +6

An improved synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI): a simplified analog of the CC-1065 alkylation subunit

Dale L. Boger, Weiya Yun, Bradley R. Teegarden · The Journal of Organic Chemistry · 1992 · 70 citations

Natural Sciences, Biochemistry, Chemistry +8

5-HT2A Inverse-Agonists for the Treatment of Insomnia

Bradley R. Teegarden, Hussien Shamma, Yifeng Xiong · Current Topics in Medicinal Chemistry · 2008 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +17

Synthesis of .alpha.-methyl 1',2'-dideoxycellobioside: a novel C-disaccharide

Robert W. Armstrong, Bradley R. Teegarden · The Journal of Organic Chemistry · 1992 · 45 citations

Life Sciences, Biochemistry, Chemistry +8

Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia

Hussien Al‐Shamma, Christen M. Anderson, Emil Chuang et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 38 citations

Medicine, Neuroscience, Pharmacology +17

1–5 of 11